Class Action Suit Filed Against Paracelsus Healthcare Corp. and Its Officers and Directors Alleging Misrepresentations and False Financial Statements.SAN DIEGO--(BUSINESS WIRE)--Oct. 11, 1996--A class action has been commenced in the California Superior Court for Los Angeles Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. County by plaintiffs Rajeshwar Gaonkar and Thomas R. Bell on behalf of purchasers of Paracelsus Healthcare Corporation ("Paracelsus") common stock during the period August 13, 1996 to October 9, 1996. The complaint charges Paracelsus and certain of its officers and directors with violations of the California Corporations and Civil Codes and violation of the Federal Securities Act of 1933 due to defendants' issuance of false and misleading financial statements in connection with, inter alia [Latin, Among other things.] A phrase used in Pleading to designate that a particular statute set out therein is only a part of the statute that is relevant to the facts of the lawsuit and not the entire statute. , (1) Paracelsus' acquisition, with stock issued pursuant to an S-4 registration statement, of Champion Healthcare Corporation ("Champion"); (2) the sale pursuant to a registration statement effective on or about August 15, 1996 of $325,000,000 of 10% Senior Subordinated Notes; and (3) the sale pursuant to an S-1 registration statement effective on or about August 15, 1996 of 4,600,000 shares of Paracelsus stock at $8.50 per share. These false financial statements permitted Paracelsus to complete the acquisition of Champion and the note and stock offerings. Paracelsus' stock traded as high as $10-1/2 during the Class Period and closed at $10-1/8 on October 9, 1996. The notes traded as high as $103.30. After the market closed on October 9, 1996, Paracelsus stunned its investors by revealing in a press release that financial results for the quarter ending September 30, 1996 would be "substantially lower than expected." The release stated that the Company expected to report a "significantly larger loss for the quarter than anticipated" due to "lower operating results of psychiatric and certain other Los Angeles metropolitan area hospitals; reimbursement accounting issues; and the need to revise allowances for certain accounts receivable accounts receivable n. the amounts of money due or owed to a business or professional by customers or clients. Generally, accounts receivable refers to the total amount due and is considered in calculating the value of a business or the business' problems in paying ." The release revealed that Paracelsus' Board of Directors had appointed a special committee to investigate "the nature and reasons for the shortfall" and to "explore accounting and financial reporting practices and procedures, including certain corporate reserve practices, in the periods before the quarter ending September 30, 1996." The press release also revealed that the Company expected to restate its financial results and amend its quarterly reports on Form 10-Q Form 10-Q See 10-Q. for the quarters ended December 31, 1995, March 31, 1996, and June 30, 1996. The release revealed that there would likely be "adjustments relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the use of reserves and recognition of certain bad debt expenses, collection expenses, and facilities closure costs." The press release also revealed that the Company was reviewing the status of its compliance under its senior bank credit agreement. Trading in the securities of Paracelsus was halted. These stunning announcements come less than two months after Paracelsus completed its acquisition of Champion for about $168 million of Paracelsus stock, issued and sold $325 million of debt securities and issued and sold nearly $40 million of common stock. Plaintiffs who have sued seek to recover damages on behalf of all purchasers of Paracelsus common stock during the Class Period (the "Class"). They are represented by three law firms This list of the world's largest law firms by revenue is taken from The Lawyer and The American Lawyer and is ordered by 2006 revenue:[1]
Milberg Weiss has been actively engaged in commercial litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , emphasizing securities and antitrust class actions, for more than 20 years. The firm has offices in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden and Los Angeles and is active in major litigations pending in federal and state courts throughout the United States. The firm's reputation for excellence has been recognized on repeated occasions by courts which have appointed the firm to major positions in complex multi-district or consolidated litigations. Milberg Weiss has taken a lead role in numerous important actions on behalf of defrauded investors, and has been responsible for a number of outstanding recoveries which, in the aggregate, total approximately $2 billion. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiffs' counsel, William Lerach or Alan Schulman of Milberg Weiss at 800/348-6192, Frederic S. Fox of Kaplan, Kilsheimer at 800/290-1952 or Stuart H. Savett of Savett Frutkin at 215/923-5400. CONTACT: Milberg Weiss Bershad Hynes & Lerach LLP William Lerach, 800/348-6192 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion